| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| RAR-related orphan receptor gamma | 7 | 0 | 0 | 7 |
| ATAD5 protein, partial | 6 | 0 | 0 | 6 |
| GLS protein | 6 | 0 | 0 | 6 |
| Microtubule-associated protein tau | 4 | 0 | 0 | 4 |
| Smad3 | 4 | 0 | 0 | 4 |
| aldehyde dehydrogenase 1 family, member A1 | 10 | 0 | 0 | 10 |
| thyroid stimulating hormone receptor | 6 | 0 | 0 | 6 |
| nuclear receptor subfamily 1, group I, member 3 | 7 | 0 | 0 | 7 |
| progesterone receptor | 6 | 0 | 0 | 6 |
| EWS/FLI fusion protein | 8 | 0 | 0 | 8 |
| retinoic acid nuclear receptor alpha variant 1 | 7 | 0 | 0 | 7 |
| retinoid X nuclear receptor alpha | 7 | 0 | 0 | 7 |
| estrogen-related nuclear receptor alpha | 12 | 0 | 0 | 12 |
| estrogen nuclear receptor alpha | 13 | 0 | 0 | 13 |
| peroxisome proliferator activated receptor gamma | 5 | 0 | 0 | 5 |
| aryl hydrocarbon receptor | 5 | 0 | 0 | 5 |
| chromobox protein homolog 1 | 6 | 0 | 0 | 6 |
| thyroid hormone receptor beta isoform 2 | 9 | 0 | 0 | 9 |
| peripheral myelin protein 22 | 5 | 0 | 0 | 5 |
| cytochrome P450 3A4 isoform 1 | 6 | 0 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit pi | 6 | 3 | 0 | 9 |
| ATP-binding cassette sub-family C member 3 | 0 | 9 | 0 | 9 |
| Multidrug resistance-associated protein 4 | 0 | 9 | 0 | 10 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 12 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
| Bile salt export pump | 0 | 3 | 0 | 3 |
| Voltage-dependent calcium channel gamma-2 subunit | 4 | 0 | 0 | 4 |
| Bile salt export pump | 0 | 17 | 0 | 17 |
| Cytochrome P450 2B1 | 0 | 0 | 0 | 1 |
| Cytochrome P450 1A1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 4 | 0 | 4 |
| Carbonic anhydrase 2 | 0 | 4 | 0 | 4 |
| Myoglobin | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A1 | 0 | 3 | 1 | 5 |
| Cytochrome P450 1A2 | 0 | 3 | 0 | 4 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
| Cytochrome P450 3A4 | 0 | 5 | 0 | 5 |
| Cytochrome P450 2D6 | 0 | 5 | 0 | 5 |
| Cytochrome P450 2C9 | 0 | 3 | 0 | 3 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 6 | 3 | 0 | 9 |
| Sulfotransferase 1A1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 6 | 3 | 0 | 9 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 6 | 3 | 0 | 9 |
| UDP-glucuronosyltransferase 1-6 | 0 | 0 | 0 | 1 |
| Glutamate receptor 2 | 4 | 0 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 6 | 3 | 0 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 6 | 3 | 0 | 9 |
| Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 4 | 0 | 3 | 0 | 3 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 6 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 6 | 3 | 0 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 6 | 3 | 0 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 6 | 3 | 0 | 9 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 6 | 3 | 0 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 6 | 3 | 0 | 9 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 7 | 0 | 2 | 0 | 2 |
| Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
| Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 6 | 3 | 0 | 9 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 6 | 3 | 0 | 9 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 6 | 3 | 0 | 9 |
| Carbonic anhydrase 9 | 0 | 2 | 0 | 2 |
| GABA theta subunit | 6 | 3 | 0 | 9 |
| Canalicular multispecific organic anion transporter 1 | 0 | 9 | 0 | 9 |
| Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit epsilon | 6 | 3 | 0 | 9 |
| Carbonic anhydrase 14 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 0 | 2 |
| toxin B | 0 | 0 | 0 | 1 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 6 | 0 | 0 | 6 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 5 | 0 | 0 | 5 |
| Chain A, HADH2 protein | 5 | 0 | 0 | 5 |
| Chain B, HADH2 protein | 5 | 0 | 0 | 5 |
| Chain A, 2-oxoglutarate Oxygenase | 6 | 0 | 0 | 6 |
| Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain A, Cruzipain | 1 | 0 | 0 | 1 |
| Chain A, Transthyretin | 0 | 0 | 1 | 1 |
| Chain A, Transthyretin | 0 | 0 | 1 | 1 |
| Chain A, Transthyretin | 0 | 0 | 1 | 1 |
| Chain A, Transthyretin | 0 | 0 | 1 | 1 |
| Chain B, Transthyretin | 0 | 0 | 1 | 1 |
| Chain A, Transthyretin | 0 | 0 | 1 | 1 |
| Chain B, Transthyretin | 0 | 0 | 1 | 1 |
| Chain A, Casein kinase II subunit alpha | 0 | 1 | 0 | 1 |
| Chain A, Casein kinase II subunit alpha | 0 | 1 | 0 | 1 |
| Chain A, Casein Kinase Ii Subunit Alpha | 0 | 1 | 0 | 1 |
| Luciferase | 2 | 0 | 0 | 2 |
| interleukin 8 | 2 | 0 | 0 | 2 |
| endonuclease IV | 1 | 0 | 0 | 1 |
| BRCA1 | 1 | 0 | 0 | 1 |
| RGS12 | 1 | 0 | 0 | 1 |
| 15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
| phosphopantetheinyl transferase | 6 | 0 | 0 | 6 |
| hypoxia-inducible factor 1 alpha subunit | 2 | 0 | 0 | 2 |
| USP1 protein, partial | 4 | 0 | 0 | 4 |
| NFKB1 protein, partial | 3 | 0 | 0 | 3 |
| PPM1D protein | 3 | 0 | 0 | 3 |
| TDP1 protein | 11 | 0 | 0 | 11 |
| GLI family zinc finger 3 | 10 | 0 | 0 | 10 |
| Thrombopoietin | 3 | 0 | 0 | 3 |
| AR protein | 10 | 0 | 0 | 10 |
| apical membrane antigen 1, AMA1 | 3 | 0 | 0 | 3 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 4 | 0 | 0 | 4 |
| estrogen receptor 2 (ER beta) | 3 | 0 | 0 | 3 |
| regulator of G-protein signaling 4 | 4 | 0 | 0 | 4 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 9 | 0 | 0 | 9 |
| glucocorticoid receptor [Homo sapiens] | 5 | 0 | 0 | 5 |
| farnesoid X nuclear receptor | 3 | 0 | 0 | 3 |
| pregnane X nuclear receptor | 8 | 0 | 0 | 8 |
| G | 3 | 0 | 0 | 3 |
| cytochrome P450 2D6 | 9 | 0 | 0 | 9 |
| Neuraminidase | 0 | 2 | 0 | 2 |
| 67.9K protein | 2 | 0 | 0 | 2 |
| glucocerebrosidase | 4 | 0 | 0 | 4 |
| Parkin | 1 | 0 | 0 | 1 |
| peroxisome proliferator-activated receptor delta | 4 | 0 | 0 | 4 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 5 | 0 | 0 | 5 |
| arylsulfatase A | 4 | 0 | 0 | 4 |
| pyruvate kinase | 1 | 0 | 0 | 1 |
| IDH1 | 2 | 0 | 0 | 2 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 3 | 0 | 0 | 3 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 4 | 0 | 0 | 4 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 7 | 0 | 0 | 7 |
| Histone H2A.x | 4 | 0 | 0 | 4 |
| Replicase polyprotein 1ab | 0 | 2 | 1 | 3 |
| cytochrome P450 2D6 isoform 1 | 6 | 0 | 0 | 6 |
| NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
| peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
| hemoglobin subunit beta | 1 | 0 | 0 | 1 |
| cellular tumor antigen p53 isoform a | 2 | 0 | 0 | 2 |
| cytochrome P450 2C19 precursor | 3 | 0 | 0 | 3 |
| cytochrome P450 2C9 precursor | 3 | 0 | 0 | 3 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 4 | 0 | 0 | 4 |
| thyroid hormone receptor beta isoform a | 4 | 0 | 0 | 4 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 2 | 0 | 0 | 2 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| heat shock protein beta-1 | 3 | 0 | 0 | 3 |
| guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1 | 1 | 0 | 0 | 1 |
| glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
| mitogen-activated protein kinase 1 | 5 | 0 | 0 | 5 |
| flap endonuclease 1 | 3 | 0 | 0 | 3 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 3 | 0 | 0 | 3 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 7 | 0 | 0 | 7 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 3 | 0 | 0 | 3 |
| DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
| DNA polymerase iota isoform a (long) | 3 | 0 | 0 | 3 |
| nuclear receptor ROR-gamma isoform 1 | 4 | 0 | 0 | 4 |
| geminin | 8 | 0 | 0 | 8 |
| DNA polymerase kappa isoform 1 | 3 | 0 | 0 | 3 |
| survival motor neuron protein isoform d | 3 | 0 | 0 | 3 |
| M-phase phosphoprotein 8 | 4 | 0 | 0 | 4 |
| lamin isoform A-delta10 | 12 | 0 | 0 | 12 |
| pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
| neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
| Polyphenol oxidase 2 | 0 | 3 | 0 | 4 |
| Aldo-keto reductase family 1 member B10 | 0 | 2 | 0 | 2 |
| G2/mitotic-specific cyclin-B2 | 0 | 1 | 0 | 1 |
| Poly [ADP-ribose] polymerase tankyrase-1 | 0 | 1 | 0 | 1 |
| Lysozyme C-1 | 0 | 1 | 0 | 1 |
| Cationic trypsin | 0 | 1 | 0 | 1 |
| Interferon beta | 5 | 0 | 0 | 5 |
| HLA class I histocompatibility antigen, B alpha chain | 3 | 0 | 0 | 3 |
| Transthyretin | 0 | 1 | 1 | 3 |
| Estrogen receptor | 0 | 1 | 0 | 1 |
| Glucocorticoid receptor | 0 | 0 | 0 | 1 |
| Cellular tumor antigen p53 | 7 | 0 | 0 | 7 |
| Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
| Integrin beta-3 | 2 | 1 | 0 | 3 |
| Myeloperoxidase | 0 | 3 | 0 | 3 |
| Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
| Beta-glucuronidase | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 7 | 0 | 7 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 3 |
| ATP-dependent translocase ABCB1 | 0 | 0 | 1 | 2 |
| Neutrophil elastase | 0 | 2 | 0 | 2 |
| Integrin alpha-IIb | 2 | 1 | 0 | 3 |
| Ornithine decarboxylase | 1 | 0 | 0 | 1 |
| Poly [ADP-ribose] polymerase 1 | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1a | 0 | 2 | 1 | 3 |
| Replicase polyprotein 1ab | 0 | 2 | 1 | 3 |
| Replicase polyprotein 1ab | 0 | 2 | 1 | 3 |
| Replicase polyprotein 1ab | 0 | 2 | 1 | 3 |
| Androgen receptor | 0 | 1 | 0 | 2 |
| Sialidase | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase pim-1 | 0 | 1 | 0 | 2 |
| Aromatase | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 8 | 0 | 8 |
| Cystic fibrosis transmembrane conductance regulator | 0 | 1 | 1 | 2 |
| 17-beta-hydroxysteroid dehydrogenase type 1 | 0 | 1 | 0 | 1 |
| Pyruvate kinase PKM | 0 | 1 | 0 | 1 |
| G2/mitotic-specific cyclin-B1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
| Urease subunit alpha | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
| G2/mitotic-specific cyclin-B | 0 | 1 | 0 | 1 |
| Mucin-1 | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
| Casein kinase II subunit alpha' | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-5 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
| Substance-P receptor | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 3 | 0 | 4 |
| Receptor-type tyrosine-protein kinase FLT3 | 0 | 1 | 0 | 1 |
| Testosterone 17-beta-dehydrogenase 3 | 0 | 1 | 0 | 1 |
| 17-beta-hydroxysteroid dehydrogenase type 2 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
| Delta-type opioid receptor | 0 | 1 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 3 | 0 | 4 |
| Homeobox protein Nkx-2.5 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase SYK | 0 | 1 | 1 | 2 |
| Histamine H2 receptor | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 alpha | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 0 | 1 | 1 |
| Death-associated protein kinase 1 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 10 | 0 | 1 | 0 | 1 |
| Beta-secretase 1 | 0 | 1 | 0 | 2 |
| Casein kinase II subunit beta | 0 | 1 | 0 | 1 |
| Casein kinase II subunit alpha | 0 | 2 | 0 | 2 |
| Urease subunit beta | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 0 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 3 | 0 | 0 | 3 |
| Lactoperoxidase | 0 | 2 | 0 | 2 |
| Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
| MO15-related protein kinase Pfmrk | 0 | 1 | 0 | 1 |
| Inositol monophosphatase 1 | 5 | 0 | 0 | 5 |
| Cyclin-dependent kinase 6 | 0 | 1 | 0 | 1 |
| Cyclin-dependent-like kinase 5 | 0 | 1 | 0 | 1 |
| Cyclin homolog | 0 | 1 | 0 | 1 |
| Transcription factor GATA-4 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 5 activator 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
| Cytochrome P450 1B1 | 0 | 3 | 0 | 3 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
| Substance-K receptor | 0 | 1 | 0 | 1 |
| Reverse transcriptase/RNaseH | 0 | 1 | 0 | 1 |
| Integrase | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
| Casein kinase II subunit alpha 3 | 0 | 1 | 0 | 1 |
| Inositol polyphosphate multikinase | 0 | 1 | 0 | 1 |
| G2/mitotic-specific cyclin-B3 | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 3 | 0 | 0 | 3 |
| Estrogen receptor beta | 0 | 1 | 0 | 1 |
| Enoyl-acyl-carrier protein reductase | 0 | 1 | 0 | 1 |
| Aurora kinase B | 0 | 1 | 0 | 1 |
| NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
| ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
| Ataxin-2 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
| Myocilin | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
| Prenyltransferase homolog | 0 | 0 | 0 | 1 |
| Poly [ADP-ribose] polymerase tankyrase-2 | 0 | 1 | 0 | 1 |
| MAP kinase-interacting serine/threonine-protein kinase 2 | 0 | 1 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
| NADPH oxidase 4 | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 3 | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 0 | 1 | 1 |
| Inositol hexakisphosphate kinase 2 | 0 | 1 | 0 | 1 |
| Short transient receptor potential channel 5 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
| Sialidase-2 | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9, partial | 3 | 0 | 0 | 3 |
| 2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 1 | 0 | 0 | 1 |
| ATP-dependent phosphofructokinase | 4 | 0 | 0 | 4 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase A chain | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 2 | 2 | 4 |
| Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 4 | 1 | 5 |
| Alpha-2B adrenergic receptor | 0 | 11 | 0 | 11 |
| Alpha-2C adrenergic receptor | 0 | 11 | 0 | 11 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
| Cytochrome P450 3A5 | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 2 |
| D(1A) dopamine receptor | 0 | 9 | 0 | 9 |
| Cytochrome P450 3A7 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2C | 0 | 15 | 0 | 15 |
| Caspase-1 | 0 | 0 | 1 | 1 |
| Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 2 | 0 | 1 | 1 | 3 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 3 | 3 |
| Spike glycoprotein | 9 | 1 | 1 | 11 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| N-acylethanolamine-hydrolyzing acid amidase | 0 | 1 | 0 | 1 |
| Heat sensitive channel TRPV3 | 0 | 1 | 1 | 2 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 1 | 2 | 3 |
| Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 1 | 2 |
| Transient receptor potential cation channel subfamily M member 8 | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 4 | 0 | 1 | 1 | 2 |
| Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 1 | 2 |
| G-protein coupled receptor 55 | 0 | 0 | 1 | 1 |
| Diacylglycerol lipase-alpha | 0 | 1 | 0 | 1 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| SMAD family member 2 | 2 | 0 | 0 | 2 |
| SMAD family member 3 | 2 | 0 | 0 | 2 |
| caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
| caspase-3 | 2 | 0 | 0 | 2 |
| euchromatic histone-lysine N-methyltransferase 2 | 13 | 0 | 0 | 13 |
| thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| D(1A) dopamine receptor | 5 | 0 | 0 | 5 |
| caspase-3 | 1 | 0 | 0 | 1 |
| muscarinic acetylcholine receptor M1 | 4 | 0 | 0 | 4 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 3 | 0 | 0 | 3 |
| 5-hydroxytryptamine receptor 4 | 0 | 14 | 0 | 14 |
| Muscarinic acetylcholine receptor M2 | 0 | 8 | 0 | 8 |
| Muscarinic acetylcholine receptor M4 | 0 | 12 | 0 | 12 |
| Muscarinic acetylcholine receptor M5 | 0 | 11 | 0 | 11 |
| Muscarinic acetylcholine receptor M1 | 0 | 9 | 1 | 10 |
| Muscarinic acetylcholine receptor M3 | 0 | 9 | 0 | 9 |
| Histamine H2 receptor | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 2A | 0 | 15 | 0 | 15 |
| D(3) dopamine receptor | 0 | 14 | 0 | 14 |
| 5-hydroxytryptamine receptor 2B | 0 | 16 | 0 | 16 |
| 5-hydroxytryptamine receptor 6 | 0 | 8 | 0 | 9 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 10 | 0 | 10 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 7 | 0 | 7 |
| Sigma non-opioid intracellular receptor 1 | 0 | 6 | 0 | 6 |
| acetylcholinesterase | 6 | 0 | 0 | 6 |
| thioredoxin reductase | 3 | 0 | 0 | 3 |
| Fumarate hydratase | 1 | 0 | 0 | 1 |
| GALC protein | 1 | 0 | 0 | 1 |
| polyprotein | 1 | 0 | 0 | 1 |
| alpha-galactosidase | 2 | 0 | 0 | 2 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 3 | 0 | 0 | 3 |
| atrial natriuretic peptide receptor 2 precursor | 2 | 0 | 0 | 2 |
| serine/threonine-protein kinase mTOR isoform 1 | 3 | 0 | 0 | 3 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 12 | 0 | 12 |
| D(2) dopamine receptor | 0 | 13 | 0 | 13 |
| D | 0 | 3 | 0 | 4 |
| Retinoic acid receptor RXR-alpha | 0 | 0 | 3 | 3 |
| Sodium-dependent noradrenaline transporter | 0 | 7 | 0 | 7 |
| Alpha-1D adrenergic receptor | 0 | 10 | 0 | 10 |
| Sodium-dependent serotonin transporter | 0 | 8 | 0 | 8 |
| Histamine H1 receptor | 0 | 10 | 1 | 11 |
| 5-hydroxytryptamine receptor 3A | 0 | 5 | 1 | 6 |
| D(2) dopamine receptor | 0 | 6 | 0 | 7 |
| Multidrug and toxin extrusion protein 2 | 0 | 2 | 0 | 2 |
| Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 3B | 0 | 5 | 1 | 6 |
| activating transcription factor 6 | 3 | 0 | 0 | 3 |
| Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
| vitamin D3 receptor isoform VDRA | 3 | 0 | 0 | 3 |
| muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
| Chain A, Beta-lactamase | 3 | 0 | 0 | 3 |
| glp-1 receptor, partial | 3 | 0 | 0 | 3 |
| DNA polymerase beta | 2 | 0 | 0 | 2 |
| lethal factor (plasmid) | 2 | 0 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 9 | 0 | 9 |
| 5-hydroxytryptamine receptor 1B | 0 | 8 | 0 | 8 |
| N-acetyltransferase Eis | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Chain A, Dihydrofolate reductase | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
| acid sphingomyelinase | 1 | 0 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 0 | 1 | 1 |
| Alpha-synuclein | 1 | 0 | 0 | 1 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 2 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 0 | 0 | 1 |
| Multidrug resistance associated protein | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 2 | 0 | 0 | 2 |
| Dopamine beta-hydroxylase | 0 | 2 | 0 | 2 |
| Lactoperoxidase | 0 | 1 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3E | 0 | 2 | 2 | 5 |
| Solute carrier family 22 member 1 | 0 | 5 | 0 | 6 |
| 5-hydroxytryptamine receptor 3B | 0 | 2 | 2 | 5 |
| Albumin | 0 | 0 | 2 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 4 | 0 | 4 |
| Alpha-1B adrenergic receptor | 0 | 3 | 0 | 3 |
| D(3) dopamine receptor | 0 | 3 | 0 | 3 |
| Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 3 | 0 | 3 |
| Alpha-1D adrenergic receptor | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 3A | 0 | 2 | 0 | 2 |
| D(1B) dopamine receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1D | 0 | 2 | 0 | 2 |
| D(4) dopamine receptor | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 1F | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
| Alpha-1A adrenergic receptor | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 3A | 0 | 3 | 2 | 6 |
| 5-hydroxytryptamine receptor 7 | 0 | 4 | 0 | 4 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 3 |
| 5-hydroxytryptamine receptor 3D | 0 | 2 | 2 | 5 |
| 5-hydroxytryptamine receptor 3C | 0 | 2 | 2 | 5 |
| 5-hydroxytryptamine receptor 3B | 0 | 2 | 0 | 2 |
| FAD-linked sulfhydryl oxidase ALR | 0 | 0 | 0 | 1 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| D(4) dopamine receptor | 0 | 4 | 0 | 4 |
| UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Histamine H1 receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
| Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Transporter | 0 | 1 | 0 | 1 |
| Transporter | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 3 | 0 | 3 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 3 | 1 | 4 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 0 | 2 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Interleukin-6 receptor subunit alpha | 0 | 1 | 0 | 1 |
| Beta-3 adrenergic receptor | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
| Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
| Histamine H1 receptor | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 5B | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Thyrotropin-releasing hormone receptor | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
| Glycine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Leukotriene B4 receptor 1 | 0 | 1 | 0 | 1 |
| Nischarin | 0 | 1 | 0 | 1 |
| Mcl-1 | 0 | 1 | 0 | 1 |
| nonstructural protein 1 | 1 | 0 | 0 | 1 |
| bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
| Snq2p | 0 | 0 | 0 | 2 |
| neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
| urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
| plasminogen precursor | 1 | 0 | 0 | 1 |
| urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
| Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
| Pleiotropic ABC efflux transporter of multiple drugs | 0 | 2 | 0 | 4 |
| D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
| Spike glycoprotein | 0 | 1 | 1 | 2 |
| huntingtin isoform 2 | 1 | 0 | 0 | 1 |
| Transmembrane protease serine 2 | 0 | 1 | 1 | 2 |
| Major prion protein | 0 | 0 | 1 | 1 |
| Procathepsin L | 0 | 1 | 1 | 2 |
| Calmodulin-1 | 0 | 1 | 0 | 1 |
| Trypanothione reductase | 0 | 2 | 0 | 2 |
| Calmodulin | 0 | 0 | 1 | 1 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme 2 | 0 | 1 | 1 | 2 |
| Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
| NADH-cytochrome b5 reductase 3 | 0 | 1 | 0 | 1 |
| Thyroid peroxidase | 0 | 1 | 0 | 1 |
| Taste receptor type 2 member 38 | 0 | 0 | 1 | 2 |
| histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
| Pyridoxal kinase | 0 | 0 | 0 | 2 |
| Aldehyde oxidase | 0 | 1 | 0 | 1 |
| Receptor-type tyrosine-protein phosphatase beta | 0 | 0 | 0 | 1 |
| Low molecular weight phosphotyrosine protein phosphatase | 0 | 1 | 0 | 1 |
| P2X purinoceptor 1 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 1 | 0 | 1 | 0 | 1 |
| P2X purinoceptor 4 | 0 | 0 | 1 | 1 |
| Trans-sialidase | 0 | 1 | 0 | 1 |
| Trans-sialidase | 0 | 1 | 0 | 1 |
| P2X purinoceptor 2 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M5 | 0 | 1 | 0 | 1 |
| Cereblon isoform 4 | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| DNA-binding protein Ikaros | 0 | 0 | 0 | 1 |
| DNA damage-binding protein 1 | 0 | 1 | 1 | 2 |
| Protein cereblon | 0 | 2 | 1 | 4 |
| Chain A, ykoF | 0 | 0 | 1 | 1 |
| Chain B, ykoF | 0 | 0 | 1 | 1 |
| Chain A, ThiT | 0 | 0 | 1 | 1 |
| Thiamine transporter ThiT | 0 | 0 | 1 | 1 |
| Transketolase | 0 | 0 | 1 | 1 |
| Thiamine-binding periplasmic protein | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
| serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
| Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
| Thyroid hormone receptor alpha | 0 | 0 | 1 | 1 |
| Thyroid hormone receptor beta | 0 | 0 | 1 | 1 |
| Proliferating cell nuclear antigen | 0 | 1 | 0 | 1 |
| Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
| Bile acid receptor | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 0 | 0 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
| Protease | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |